|
YY2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.242000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.967780E-01 |
| Normal-vs-Stage2 |
8.866600E-01 |
| Normal-vs-Stage3 |
1.461240E-01 |
| Normal-vs-Stage4 |
6.539000E-01 |
| Stage1-vs-Stage2 |
3.214800E-01 |
| Stage1-vs-Stage3 |
2.815700E-02 |
| Stage1-vs-Stage4 |
4.667000E-01 |
| Stage2-vs-Stage3 |
3.290200E-01 |
| Stage2-vs-Stage4 |
7.150200E-01 |
| Stage3-vs-Stage4 |
8.828800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.340200E-01 |
| Normal-vs-AfricanAmerican |
8.999600E-01 |
| Normal-vs-Asian |
3.226600E-01 |
| Caucasian-vs-AfricanAmerican |
7.498600E-01 |
| Caucasian-vs-Asian |
4.940600E-01 |
| AfricanAmerican-vs-Asian |
5.895200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.156400E-01 |
| Normal-vs-Female |
1.895770E-03 |
| Male-vs-Female |
1.79227999999032E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.253400E-01 |
| Normal-vs-Extreme_Weight |
1.005170E-01 |
| Normal-vs-Obese |
3.519600E-01 |
| Normal-vs-Extreme_Obese |
7.011800E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.278400E-02 |
| Normal_Weight-vs-Obese |
7.546800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.655560E-02 |
| Extreme_Weight-vs-Obese |
1.097590E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.576000E-01 |
| Obese-vs-Extreme_Obese |
4.262800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.119600E-02 |
| Normal-vs-Age(41-60Yrs) |
2.098200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.487790E-01 |
| Normal-vs-Age(81-100Yrs) |
7.117400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.142190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.220200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.747600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.224200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.727000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.316600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.752600E-01 |
| Normal-VS-Type2 PRCC |
4.280600E-01 |
| Normal-VS-KIRP CIMP |
1.270570E-01 |
| Normal-VS-Unclassified PRCC |
3.890300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.788400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.070100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.918100E-03 |
| Type2 PRCC-VS-KIRP CIMP |
1.827790E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.583650E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.033200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.287000E-01 |
| Normal-vs-N1 |
8.087700E-02 |
| Normal-vs-N2 |
2.748200E-01 |
| N0-vs-N1 |
1.458250E-01 |
| N0-vs-N2 |
2.851400E-01 |
| N1-vs-N2 |
3.934200E-01 |
|
|
